SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABAX --- lots of upside
ABAX 83.000.0%Aug 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: burner who wrote (411)4/2/1998 11:39:00 AM
From: Yo Yo  Read Replies (1) of 492
 
A question.

Why is company spending money on Investor relations flyers (to
people who already own shares, but that's another thing) unless
they are are trying to go to the equity market to issue more shares?
The company is already tight for cash, still has negative
operating cash flow, and needs to spend more money increasing
development of new panels.

If things are going good, the results will speak for themselves.
Year end results will be out soon. ( or won't be, if things aren't
going so well).

I also didn't notice mention of the profitable Dade-Behring
unit that competes with ABAX.

Smells like a Reg-S or convertible debt offering is on the way.

Just isn't making sense.

As you may have guessed, I don't own any shares, YET!

Yo Yo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext